TY - ICOMM AB - Why, when human-relevant evidence of likely efficacy can be generated before a trial begins, is it not evaluated before patients are exposed? M1 - 2026-08-27 N2 - Why, when human-relevant evidence of likely efficacy can be generated before a trial begins, is it not evaluated before patients are exposed? TI - It Is Time To Require Human-Relevant Efficacy Evidence Before First-In-Human Trials UR - https://www.drugdiscoveryonline.com/doc/it-is-time-to-require-human-relevant-efficacy-evidence-before-first-in-human-trials-0001 Y2 - 2026-08-27 ER -